A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 159,500 shares of ELAN stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,500
Previous 206,300 22.69%
Holding current value
$2.15 Million
Previous $2.98 Million 21.34%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.85 - $15.47 $62.6 Million - $81.8 Million
-5,285,434 Reduced 41.36%
7,494,299 $110 Million
Q2 2024

Aug 14, 2024

BUY
$12.93 - $18.45 $9.03 Million - $12.9 Million
698,005 Added 5.78%
12,779,733 $184 Million
Q1 2024

May 15, 2024

BUY
$14.37 - $16.46 $26.7 Million - $30.6 Million
1,859,620 Added 18.19%
12,081,728 $197 Million
Q4 2023

Feb 14, 2024

SELL
$8.6 - $14.94 $30.9 Million - $53.7 Million
-3,593,495 Reduced 26.01%
10,222,108 $152 Million
Q3 2023

Nov 14, 2023

BUY
$9.81 - $12.62 $5.49 Million - $7.06 Million
559,193 Added 4.22%
13,815,603 $155 Million
Q2 2023

Aug 14, 2023

BUY
$8.08 - $10.37 $77.6 Million - $99.6 Million
9,602,677 Added 262.82%
13,256,410 $133 Million
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $10.5 Million - $17.4 Million
1,191,064 Added 48.36%
3,653,733 $34.3 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $95.6 Million - $114 Million
-8,322,076 Reduced 77.17%
2,462,669 $30.1 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $127 Million - $332 Million
10,239,562 Added 1878.19%
10,784,745 $134 Million
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $984,091 - $1.33 Million
-50,132 Reduced 8.42%
545,183 $10.7 Million
Q1 2022

May 16, 2022

SELL
$24.65 - $29.0 $15 Million - $17.6 Million
-607,141 Reduced 50.49%
595,315 $15.5 Million
Q4 2021

Feb 14, 2022

SELL
$27.74 - $34.09 $5.23 Million - $6.43 Million
-188,527 Reduced 13.55%
1,202,456 $34.1 Million
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $1.95 Million - $2.45 Million
-66,675 Reduced 4.57%
1,390,983 $44.4 Million
Q2 2021

Aug 16, 2021

SELL
$28.76 - $35.98 $5.29 Million - $6.61 Million
-183,818 Reduced 11.2%
1,457,658 $50.6 Million
Q1 2021

May 17, 2021

SELL
$27.85 - $34.49 $27.5 Million - $34 Million
-986,955 Reduced 37.55%
1,641,476 $48.3 Million
Q4 2020

Feb 16, 2021

BUY
$27.53 - $33.79 $69.1 Million - $84.8 Million
2,508,431 Added 2090.36%
2,628,431 $80.6 Million
Q3 2020

Nov 16, 2020

BUY
$21.1 - $29.13 $129,321 - $178,537
6,129 Added 5.38%
120,000 $3.35 Million
Q2 2020

Aug 14, 2020

SELL
$18.94 - $24.93 $6.33 Million - $8.33 Million
-334,263 Reduced 74.59%
113,871 $2.44 Million
Q1 2020

May 15, 2020

SELL
$16.68 - $32.25 $3.26 Million - $6.3 Million
-195,206 Reduced 30.34%
448,134 $10 Million
Q4 2019

Feb 14, 2020

SELL
$25.29 - $29.45 $5.08 Million - $5.91 Million
-200,814 Reduced 23.79%
643,340 $18.9 Million
Q3 2019

Nov 14, 2019

SELL
$25.62 - $34.96 $34.5 Million - $47.1 Million
-1,346,529 Reduced 61.47%
844,154 $22.4 Million
Q2 2019

Aug 14, 2019

SELL
$31.11 - $34.79 $176 Million - $196 Million
-5,641,514 Reduced 72.03%
2,190,683 $74 Million
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $202 Million - $229 Million
6,970,355 Added 808.77%
7,832,197 $0
Q3 2018

Nov 13, 2018

BUY
$34.1 - $36.19 $29.4 Million - $31.2 Million
861,842 New
861,842 $0

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.39B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.